Postoperative Nausea and Vomiting
Conditions
Brief summary
The purpose of this study is to determine whether continuous infusion of palonosetron after its prophylactic single injection can further reduce the incidence of postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery.
Interventions
continuous infusion of palonosetron 0.00075 mg/hour after single injection of palonosetron 0.075mg
continuous infusion of normal saline after single injection of palonosetron 0.075mg
Sponsors
Study design
Eligibility
Inclusion criteria
* ASA Physical Status 1 or 2 * Elective gynaecological laparoscopic surgery of ≥ 1h duration
Exclusion criteria
* Anti-emetics, steroids, or psychoactive medications within 24 h of study initiation * Vomiting or retching in the 24 h preceding surgery * Cancer chemotherapy within 4 weeks or emetogenic radiotherapy within 8 weeks before study entry * Ongoing vomiting from gastrointestinal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of postoperative nausea and vomiting | 24 hours after surgery |
Secondary
| Measure | Time frame |
|---|---|
| severity of nausea | for 24 hours after sugery |
Countries
South Korea